Authors: KOCH P MCCULLOUGH JR BLUM PS DEGRAW S KRAUSE AC RUBIN PD

Citation: P. Koch et al., PHARMACOKINETICS AND SAFETY OF (S)-OXYBUTYNIN IN NORMAL HEALTHY-VOLUNTEERS, The FASEB journal, 12(4), 1998, pp. 825-825

Authors: AMBROSE D ARROYO C BACHMAN M DECECCO P CONNOR D ECKHAUSE M ECKLUND KM GRAESSLE S HANCOCK AD HARTMAN K HEBERT M HOFF CH HOFFMANN GW IRWIN GM KANE JR KANEMATSU N KUANG Y LANG K LEE R MARTIN RD MCDONOUGH J MILDER A MOLZON WR POMMOTMAIA M RILEY PJ RITCHIE JL RUBIN PD VASSILAKOPOULOS VI WARE CB WELSH RE WOJCICKI SG WOLIN E WORM S

Citation: D. Ambrose et al., FIRST OBSERVATION OF THE RARE DECAY MODE K-L(0)-]E(-)()E(), Physical review letters, 81(20), 1998, pp. 4309-4312

Authors: PINCO RG RUBIN PD

Citation: Rg. Pinco et Pd. Rubin, AMBIGUITIES OF THE DIETARY-SUPPLEMENT HEALTH AND EDUCATION ACT OF 1994, Food and drug law journal, 51(3), 1996, pp. 383-405

Authors: LAURSEN LS LAURITSEN K BUKHAVE K RASKMADSEN J JACOBSEN O NAESDAL J GOEBELL H PESKAR B RUBIN PD SWANSON LJ KESTERSON JW KESHAVARZIAN A KOZAREK R HANAUER S CORT D STENSON WF

Citation: Ls. Laursen et al., SELECTIVE 5-LIPOXYGENASE INHIBITION BY ZILEUTON IN THE TREATMENT OF RELAPSING ULCERATIVE-COLITIS - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER TRIAL, European journal of gastroenterology & hepatology, 6(3), 1994, pp. 209-215